Luke Devey
Seminars
Wednesday 3rd December 2025
Panel Discussion: Comparing Immune Cell Depletion & Immune Tolerance Therapies to Accelerate Safer, Efficacious Therapies
1:40 pm
- Expand therapeutic approaches beyond B-cell depletion
- Highlight safety challenges with depletion in comparison to tolerance with Tregs
- Explore the long-term biological effects of B-cell depletion and immune reprogramming therapies
Wednesday 3rd December 2025
Exploring Autologous CD-19 CAR-Tregs for Rheumatology to Advance Treatment Development for Unmet Diseases
1:10 pm
- Explore the role of the immune system in rheumatoid scleroderma
- Hear preclinical evidence from Quell Therapeutics on their novel therapy targeting rheumatoid scleroderma
